Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

SIMPLE SUMMARY: Our explorative study used a microfluidic-based approach for circulating tumor cell (CTC) detection in 55 pancreatic ductal adenocarcinoma (PDAC) patients before treatment initiation (baseline) and during follow-up (FUP). For the first time, we assessed the expression of retinoic aci...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitschke, Christine, Markmann, Benedikt, Tölle, Marie, Kropidlowski, Jolanthe, Belloum, Yassine, Goetz, Mara R., Schlüter, Hartmut, Kwiatkowski, Marcel, Sinn, Marianne, Izbicki, Jakob, Pantel, Klaus, Güngör, Cenap, Uzunoglu, Faik G., Wikman, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497091/
https://www.ncbi.nlm.nih.gov/pubmed/36139565
http://dx.doi.org/10.3390/cancers14184405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497091/
https://www.ncbi.nlm.nih.gov/pubmed/36139565
http://dx.doi.org/10.3390/cancers14184405

Ejemplares similares